权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Research Program

研究计划

基本信息

批准号：
10382353
负责人：
Jennifer Jean Trowbridge
金额：
$ 4.91万
依托单位：
JACKSON LABORATORY
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
起止时间：
1997-08-01 至 2025-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10382353
关键词：
Abbreviations Adverse effects Animal Model Antigen-Presenting Cells Area Basic Science Biological Biological Markers Biological Models Biological Process Budgets Cancer Biology Cancer Center Cancer Center Support Grant Cancer Model Cancer Vaccines Cell model Chromosomal Rearrangement Cities Clinical Collaborations Complement Complex Computational Science Computational algorithm Computer Models Computing Methodologies Connecticut Core Grant DNA Damage DNA Repair Pathway DNA Sequence Alteration Data Set Development Direct Costs Discipline Evolution Extracellular Matrix Faculty Recruitment Fostering Foundations Funding Future Genetic Genetic Engineering Genetic Models Genetic Variation Genome Genomic Instability Genomics Goals Grant Health Human Genetics Immune checkpoint inhibitor Immunodeficient Mouse Immunologics Immunotherapy Investigation Israel Knowledge Laboratories Lead Leadership Maine Malignant Neoplasms Mediator of activation protein Medical center Medicine Methods Modeling Mus Mutation NCI Center for Cancer Research Names Oncogene Activation Output Patients Pediatric Hospitals Peer Review Phenotype Property Publications Records Research Research Personnel Research Project Summaries Research Support Resistance Resource Development Resources Sampling Southwest Oncology Group System Technology Telomere Maintenance The Jackson Laboratory Travel Tumor Suppressor Proteins Tumorigenicity United States National Institutes of Health Universities Vision Work anticancer research behavioral response biological systems cancer cell cancer genomics cancer therapy candidate marker chemotherapy computing resources design functional genomics genetic regulatory protein genetic resource genomic aberrations in vitro Model in vivo in vivo Model innovation innovative technologies meetings member model development neoplastic cell new technology novel patient derived xenograft model precision medicine precision oncology programs resistance mechanism response single cell technology technological innovation therapeutic target therapy resistant translational potential treatment response tumor tumor microenvironment

项目摘要

PROJECT SUMMARY RESEARCH PROGRAM The overarching goal of the JAX Cancer Center (JAXCC) Research Program, Genetic Models for Precision Cancer Medicine, is to advance the vision of precision oncology through basic research discoveries with potential for translational and clinical impact. Members use diverse, multi-scale strategies to deconvolute complex cancer systems to their principal components and to investigate the drivers of cancer cell complexity, tumor evolution, and tumor adaptation. Elucidating these fundamental biological processes are key to a principled, mechanistic understanding of the adverse effects of cancer therapy and of treatment resistance. During the current funding period we have expanded, and reshaped, the JAXCC into a new cancer research force with a focus on complex genetics and functional genomics. Research is organized around three complementary Specific Aims. Aim 1 seeks to develop novel organismal, cellular, and computational models of cancer, drawing on the JAXCC's longstanding strengths in model development. Aim 2 examines the genomic instability and genetic complexity of cancer and determines their functional consequences in the cancer cell. Using advanced computational methods and genomic technologies we will interrogate animal models developed in Aim 1 as well as patient samples. Aim 3 investigates how key components of a tumor and the host contribute to cancer biology, examining the cancer cell intrinsic and extrinsic components of a malignant tumor. Results from studies in Aim 3, integrated with the genetic alterations identified in Aim 2 with models developed in Aim 1, will allow us to deconvolute the complex interactions of the tumor and host microenvironments. The 53 full program members of the JAXCC include 33 on the Bar Harbor campus and 20 on the Farmington campus. Through its emphasis on basic research, unique model development, and technological innovation, the program leverages funding from multiple NIH ICs in support of cancer-focused research. More recently, we brought our technologies into the clinical arena through collaborations with SWOG, the Maine Cancer Genomics Initiative, City of Hope, Beth Israel Deaconess Medical Center, University of Connecticut Health Center, and the Connecticut Children's Hospital. The program is supported by $10,401,511 direct costs in NCI and other peer- reviewed cancer-related grants in the last budget year. Over the last grant cycle, CCSG funds have supported 379 publications including 30% intra-programmatic collaborations and 72% with external collaborators. The efforts of the Co-Program Leaders, Drs. Karolina Palucka and Roel Verhaak, and JAXCC leadership have fostered interactivity among JAXCC members through regular Research Program meetings, subsidized travel between campuses, and the JAXCC Annual Retreat. The annual JAXCC Retreat and monthly program meetings are the primary forums that bring together Cancer Center members from both campuses to develop intra- programmatic collaborations and to participate in the planning for resource development and faculty recruitment.

项目概要研究报告 JAX癌症中心（JAXCC）研究计划的首要目标是精确的遗传模型癌症医学，是通过基础研究发现推进精确肿瘤学的愿景，潜在的转化和临床影响。成员使用多样化、多尺度的策略去卷积复杂的癌症系统的主要组成部分，并研究癌细胞复杂性的驱动因素，肿瘤进化和肿瘤适应。阐明这些基本的生物过程是一个关键，对癌症治疗的副作用和治疗抗性的原则性、机械性理解。在目前的资助期间，我们已经扩大和重塑了JAXCC，使其成为一个新的癌症研究项目。重点是复杂遗传学和功能基因组学。研究围绕三个方面展开互补的具体目标。目标1寻求开发新的生物体，细胞和计算模型，癌症，利用JAXCC在模型开发方面的长期优势。目的2检查基因组癌症的不稳定性和遗传复杂性，并决定其在癌细胞中的功能后果。使用先进的计算方法和基因组技术，我们将询问动物模型开发目标1以及患者样本。目的3研究肿瘤的关键成分和宿主如何发挥作用癌症生物学，检查恶性肿瘤的癌细胞内在和外在成分。结果目标3中的研究，结合目标2中确定的遗传改变和目标1中开发的模型，将使我们能够去卷积肿瘤和宿主微环境的复杂相互作用。第53集Full JAXCC的计划成员包括巴尔港校区的33名和法明顿校区的20名。通过其对基础研究，独特的模型开发和技术创新的重视，该计划利用来自多个NIH IC的资金支持以癌症为重点的研究。最近，我们带来了我们的通过与SWOG，缅因州癌症基因组学倡议，希望之城，贝斯以色列女执事医疗中心，康涅狄格大学健康中心，以及康涅狄格州儿童医院该计划由NCI和其他同行的10，401，511美元直接费用支持，在上一个预算年度审查了与癌症有关的赠款。在上一个赠款周期，CCSG基金支持了 379篇出版物，包括30%的项目内合作和72%的外部合作者。的联合项目负责人Karolina Palucka博士和Roel Verhaak博士以及JAXCC领导层的努力，通过定期的研究计划会议，补贴旅行，促进JAXCC成员之间的互动以及JAXCC年度务虚会。年度JAXCC务虚会和月度计划会议是主要的论坛，汇集了癌症中心成员从两个校区，以发展内部，计划合作，并参与资源开发和教师招聘的规划。